Clinical Trials Directory

Trials / Completed

CompletedNCT06169462

Comparison of Pericapsular Nerve Group Block With Suprainguinal Fascia Compartment Block in Hip Fractures

Comparison of Pericapsular Nerve Group (PENG) Block Alone Versus Combined With Suprainguinal Fascia Compartment Block (SIFCB) for Postoperative Analgesia and Quality of Recovery in Older Adult Patients With Hip Fractures

Status
Completed
Phase
Study type
Observational
Enrollment
38 (actual)
Sponsor
Karaman Training and Research Hospital · Academic / Other
Sex
All
Age
65 Years – 90 Years
Healthy volunteers
Accepted

Summary

Ultrasound-guided Supra-inguinal Fascia Iliaca compartment Block (SIFCB) and Pericapsular Nerve Group Block (PENG) are increasingly being used for postoperative analgesia for hip surgery. The postoperative analgesic efficacy of SIFCB added to PENG block in elderly hip fracture patients will be evaluated. Postoperative opioid consumption and quality of recovery will also be evaluated.

Detailed description

The study was conducted as a retrospective cohort feasibility design within a tertiary hospital. Patient records and electronic data systems were used to gather the required data for analysis. Before surgery, a carefully selected cohort of patients who underwent PENG block and PENG block added SIFCB were included in the study.

Conditions

Interventions

TypeNameDescription
PROCEDUREPENG blockPatients underwent ultrasound-guided PENG Block for older adult patients surgery for hip fracture. Patients who received opioids as a rescue analgesic during postoperative pain management on selected dates will be included in the study.
PROCEDUREPENG block+ SIFCBPatients underwent ultrasound-guided PENG Block+ SIFCB for older adult patients surgery for hip fracture. Patients who received opioids as a rescue analgesic during postoperative pain management on selected dates will be included in the study.

Timeline

Start date
2023-01-31
Primary completion
2023-09-01
Completion
2023-12-10
First posted
2023-12-13
Last updated
2023-12-14

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06169462. Inclusion in this directory is not an endorsement.